Company-wide revenue
Reported revenue in 2021 ¥17.79B Reported revenue in 2025 ¥24.62B
- growth amount
- +¥6.83B
- growth annualized
- +8.5%
- growth total
- +38.4%
Japanese company profile · 4465
In its FY2025 public filing, Niitaka Co., Ltd. reports Chemicals Business, Healthcare. The page shows business-level revenue and profit where the source disclosures support comparison.
Original Japanese company name: 株式会社ニイタカ
English company name recorded in Japan's EDINET filer data. English company name source
What does this company do?
Niitaka Co., Ltd.'s largest reported business by revenue in FY2025 was Chemicals Business.
The business with the highest reported segment profit in FY2025 was Chemicals Business.
FY2025 · fiscal year ended May 2026 View original filing ↗ The source document may be in Japanese.
Business structure
| Business | Sales | Revenue share | Operating profit |
|---|---|---|---|
| Chemicals Business | ¥23.27B ↗ | 94.5% | ¥1.91B ↗ |
| Healthcare | ¥1.35B ↗ | 5.5% | ¥212.12M ↗ |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended May 2026. Revenue and profit are shown only where the filing and data support a comparison.
What is growing?
Reported revenue in 2021 ¥17.79B Reported revenue in 2025 ¥24.62B
This describes a reported period; it is not a forecast.
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
FY2025 · fiscal year ended May 2026
The source document may be in Japanese.
Filing ID: S100YYMP
View original filing ↗Ask about this company
The source document may be in Japanese.